Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
The δ-opioid receptor (δOR) has been considered as a therapeutic target in multiple neurological and neuropsychiatric disorders particularly as δOR agonists are deemed safer alternatives relative to the more abuse-liable µ-opioid receptor drugs. Clinical development of δOR agonists, however, has bee...
Saved in:
Main Authors: | Arryn T. Blaine (Author), Yiming Miao (Author), Jinling Yuan (Author), Sophia Palant (Author), Rebecca J. Liu (Author), Zhong-Yin Zhang (Author), Richard. M. van Rijn (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment
by: Alexander R. French, et al.
Published: (2023) -
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
by: Yazan J. Meqbil, et al.
Published: (2022) -
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
by: Kendall L. Mores, et al.
Published: (2019) -
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
by: Anna M. Gutridge, et al.
Published: (2021) -
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects
by: Alexander R. French, et al.
Published: (2022)